Clinical Trials Update: June 26, 2007
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
712506
GlaxoSmithKline Plc announced further  clinical trial results on Sunday underlining the ability of a  drug combination including its product Tykerb to fight breast  cancer that has spread to the brain.
761698
Treatment with Wyeth's drug temsirolimus, which secured U.S. regulatory approval on Wednesday, extended survival for 3 1/2 months for patients with advanced renal-cell carcinoma, according to a company-sponsored study.
470908
Six months after the drug industry vowed to make its clinical trials more transparent, and three months after launching a common website to give the public "unprecedented access" to studies both good and bad, drug companies have posted unpublished trial results on the site for just five drugs.
207867
TUESDAY, Nov. 9 (HealthDayNews) -- The biggest trial to date on an experimental obesity drug shows the pill is both safe and effective, researchers say.
25097
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
266095
The pharmaceutical industry made a commitment Thursday to publish more data about clinical drug trials, amid growing questions about the safety of many leading companies' medicines.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
339099
New data, from the landmark ATAC (âArimidex&#39;, Tamoxifen, Alone or in Combination) trial, is presented today at the San Antonio Breast Cancer Symposium, USA.
414089
A website goes the extra mile to make sure voters aren & rsquo;t confused this Tuesday.  Also: West Virginia organizes the first public supercomputer & hellip;.  FDA keeps its eye on a new pain relief drug & hellip;. and more.
101669
A new analysis finds that clinical trials of breast-cancer treatments by drugmakers show positive results far more often than non-industry trials. Why the difference?
303689
Acorda announces positive clinical trial data.
402115
Two drugs provide good results in preliminary trials.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
727464
roundup Plus: Supercomputer center gets new No. 2...MIT, Caltech offer low-tech voting advice...Siemens builds phone to detect bad breath.
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.